Anti-CD44 Antibody (Hermes-1) 

Anti-CD44 Antibody (Hermes-1) is a kind of rat IgG2a κ chimeric antibody, targeting to human CD44. Anti-CD44 Antibody (Hermes-1) blocks the binding of hyaluronan to CD44. Anti-CD44 Antibody (Hermes-1) restores (Platelet-derived Growth Factor-BB)-induced β-receptor activation and motility in fibroblasts. Anti-CD44 Antibody (Hermes-1) causes partial loss of the anti-aging effect of hyaluronic ^[1][2][3].

Rat IgG2a, κ

Rat IgG2a kappa, Isotype Control

CD44

Anti-CD44 Antibody (Hermes-1) (10 μg/mL, 12 h) increases SA-β-Gal-positive cells in human amniotic epithelial stem cells (hAECs)^[1].
Anti-CD44 Antibody (Hermes-1) (25-50 μg/mL, 27 h) restores (Platelet-derived Growth Factor-BB)-induced β-receptor activation and motility in fibroblasts^[2].
Anti-CD44 Antibody (Hermes-1) (50 μg/mL, 3 h) neutralizes the inhibitory effect of hyaluronan on PDGF-BB (Platelet-derived Growth Factor-BB)-induced β-receptor phosphorylation in fibroblasts^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Anti-CD44 Antibody (Hermes-1) (30 mg/kg, i.v., twice a week) blocks hyaluronan-CD44 interaction in MDA-MB-468 and 3T3HAS3 cells xenograft mice models^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

960  [NCBI]

P16070

ELISA, FACS, Functional assay, Research in vivo

Unconjugated

The product can be reconstituted/diluted with sterile PBS or saline.

150 kDa

Liquid

Colorless to light yellow

[Anti-CD44 Antibody (Hermes-1)]

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Yu C, et al. Hyaluronan delays human amniotic epithelial stem cell senescence by regulating CD44 isoform switch to activate AKT/mTOR signals. Biomed Pharmacother. 2024 Jan;170:116100.  [Content Brief]

  [2]. Li L, et al. Inhibition of platelet-derived growth factor-BB-induced receptor activation and fibroblast migration by hyaluronan activation of CD44. J Biol Chem. 2006 Sep 8;281(36):26512-9.  [Content Brief]

  [3]. Zhao C, et al. The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44. Oncotarget. 2019 Nov 12;10(61):6561-6576.  [Content Brief]